Show simple item record

Authordc.contributor.authorGuzmán Martínez, Leonardo 
Authordc.contributor.authorFarías, Gonzalo A. 
Authordc.contributor.authorMaccioni Baraona, Ricardo 
Admission datedc.date.accessioned2019-03-15T16:03:41Z
Available datedc.date.available2019-03-15T16:03:41Z
Publication datedc.date.issued2012
Cita de ítemdc.identifier.citationArchives of Medical Research, Volumen 43, Issue 8, 2018, Pages 663-666
Identifierdc.identifier.issn01884409
Identifierdc.identifier.issn18735487
Identifierdc.identifier.other10.1016/j.arcmed.2012.10.013
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/165885
Abstractdc.description.abstractAlzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and inexpensive biological markers for AD is a long-standing aspiration for researchers and the medical community. Here we describe some of the recent advances in the field of biomarkers, both in cerebrospinal fluid (CSF) and in peripheral blood. © 2012 IMSS.
Lenguagedc.language.isoen
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceArchives of Medical Research
Keywordsdc.subjectAlzheimer's disease
Keywordsdc.subjectBiomarkers
Keywordsdc.subjectPeripheral Marker
Keywordsdc.subjectPlatelet tau
Keywordsdc.subjectTau protein and peripheral blood
Títulodc.titleEmerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile